Latest news
Amazon Pharmacy to Offer GLP-1 Delivery Service | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 18:02:55 GMTFDA Approves Orezeyful | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 19:57:26 GMTInside CVS Health's GLP-1 Push and Earnings Beat - pharmaceuticalcommerce.compharmaceuticalcommerce.com · Thu, 06 Aug 2026 15:16:55 GMTSource Denies AstraZeneca-Bristol Myers Merger Talks | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 19:02:42 GMTPathos AI Enters Two lIcensing Deals | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 19:07:22 GMTAstraZeneca and Bristol Myers Squibb Held Merger Talks | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Mon, 03 Aug 2026 20:07:22 GMTThe 2026 Forecast Revisited: Dealmaking, Direct-to-Patient and Patient Affordability - pharmaceuticalcommerce.compharmaceuticalcommerce.com · Mon, 03 Aug 2026 16:06:45 GMTFDA Votes 10 to 3 in Favor of Replimune's Rp1 Efficacy Data | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 31 Jul 2026 07:00:00 GMT